Proto Labs (PRLB)
(Delayed Data from NYSE)
$29.36 USD
-0.73 (-2.43%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $29.36 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 103 | 80 | 78 | 162 | 161 |
Receivables | 75 | 80 | 81 | 58 | 57 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 14 | 14 | 13 | 11 | 10 |
Other Current Assets | 9 | 13 | 11 | 11 | 8 |
Total Current Assets | 201 | 187 | 183 | 242 | 236 |
Net Property & Equipment | 254 | 258 | 280 | 283 | 264 |
Investments & Advances | 8 | 26 | 14 | 59 | 13 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 300 | 305 | 439 | 143 | 146 |
Deposits & Other Assets | 5 | 5 | 4 | 5 | 3 |
Total Assets | 772 | 802 | 929 | 744 | 674 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 16 | 17 | 25 | 18 | 17 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 18 | 1 | 1 | 0 |
Accrued Expenses | 32 | 35 | 26 | 28 | 26 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 1 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 50 | 72 | 55 | 50 | 48 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 19 | 26 | 36 | 34 | 26 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 1 | 0 | 1 | 2 | 0 |
Other Non-Current Liabilities | 5 | 4 | 6 | 6 | 5 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 77 | 105 | 100 | 100 | 88 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 467 | 474 | 469 | 285 | 268 |
Retained Earnings | 256 | 258 | 377 | 363 | 325 |
Other Equity | -28 | -34 | -17 | -3 | -7 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 695 | 698 | 828 | 644 | 586 |
Total Liabilities & Shareholder's Equity | 772 | 802 | 929 | 744 | 674 |
Total Common Equity | 695 | 698 | 828 | 644 | 586 |
Shares Outstanding | 25.70 | 27.10 | 27.50 | 26.70 | 26.70 |
Book Value Per Share | 27.05 | 25.74 | 30.13 | 24.13 | 21.94 |
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 113 | 110 | 103 | 103 | 86 |
Receivables | 72 | 78 | 75 | 79 | 76 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 12 | 13 | 14 | 14 | 14 |
Other Current Assets | 10 | 9 | 9 | 9 | 9 |
Total Current Assets | 208 | 210 | 201 | 205 | 185 |
Net Property & Equipment | 244 | 248 | 254 | 243 | 249 |
Investments & Advances | 0 | 3 | 8 | 12 | 16 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 297 | 298 | 300 | 301 | 302 |
Deposits & Other Assets | 5 | 5 | 5 | 4 | 5 |
Total Assets | 758 | 770 | 772 | 784 | 777 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 16 | 15 | 16 | 18 | 16 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 17 | 17 |
Accrued Expenses | 33 | 37 | 32 | 37 | 32 |
Income Taxes Payable | 0 | 4 | 0 | 1 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 51 | 58 | 50 | 75 | 66 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 15 | 16 | 19 | 17 | 21 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 1 | 1 | 1 | 1 |
Other Non-Current Liabilities | 5 | 5 | 5 | 5 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 73 | 82 | 77 | 99 | 95 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 461 | 463 | 467 | 464 | 465 |
Retained Earnings | 253 | 253 | 256 | 251 | 247 |
Other Equity | -29 | -29 | -28 | -30 | -29 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 685 | 687 | 695 | 685 | 683 |
Total Liabilities & Shareholder's Equity | 758 | 770 | 772 | 784 | 777 |
Total Common Equity | 685 | 687 | 695 | 685 | 683 |
Shares Outstanding | 25.10 | 25.50 | 25.70 | 26.10 | 26.20 |
Book Value Per Share | 27.30 | 26.95 | 27.05 | 26.24 | 26.06 |